 | • レポートコード：QYR2104Z4421 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、154ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、パントプラゾールのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、錠剤、カプセル）、用途別市場規模（逆流性食道炎、ガストリノーマ、抗菌剤、胃腸出血、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・パントプラゾールの市場動向 ・企業の競争状況、市場シェア ・パントプラゾールの種類別市場規模（注射、錠剤、カプセル） ・パントプラゾールの用途別市場規模（逆流性食道炎、ガストリノーマ、抗菌剤、胃腸出血、その他） ・パントプラゾールの北米市場規模2016-2027（アメリカ、カナダ） ・パントプラゾールのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・パントプラゾールのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・パントプラゾールの中南米市場規模2016-2027（メキシコ、ブラジル） ・パントプラゾールの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda、Actavis (TEVA )、Mantra Pharma、Nora Pharma、Abbott、Angita Pharma、Apotex Corporation、Auro Pharma、Devonian、Ahn-Gook Pharmal、GSK、Eurofarma Laboratorios、Torrent Pharma、Zydus Pharmaceuticals/Cadila Pharma、Northeast Pharmaceutical、NCPC、Huarun Shuanghe Pharmaceutical、Nanjing Yiheng Pharmaceutical、Nanjing Changao Pharmaceutical、Harbin Yuheng Pharmaceutical、Sinopharm Group、Shandong Luye Pharmaceutical、Shandong Luoxin Pharmaceutical Group、Chengdu Baiyu Pharmaceutical、Yangzijiang Pharmaceutical、Wuxi Kaifu Pharmaceutical、Hangzhou Zhongmei Huadong Pharmaceutical、Liaoning Kangshi Pharmaceutical、Shanghai AIDEFA Pharmaceutical） ・結論 |
Pantoprazole is a first-generation proton pump inhibitor (PPI) used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome.
Market Analysis and Insights: Global Pantoprazole Market
The global Pantoprazole market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pantoprazole market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pantoprazole market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pantoprazole market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pantoprazole market.
Global Pantoprazole Scope and Market Size
Pantoprazole market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pantoprazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Tablets
Capsule
Segment by Application
Reflux Esophagitis
Gastrinoma
Antimicrobial Agents
Gastrointestinal Hemorrhage
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Takeda
Actavis (TEVA )
Mantra Pharma
Nora Pharma
Abbott
Angita Pharma
Apotex Corporation
Auro Pharma
Devonian
Ahn-Gook Pharmal
GSK
Eurofarma Laboratorios
Torrent Pharma
Zydus Pharmaceuticals/Cadila Pharma
Northeast Pharmaceutical
NCPC
Huarun Shuanghe Pharmaceutical
Nanjing Yiheng Pharmaceutical
Nanjing Changao Pharmaceutical
Harbin Yuheng Pharmaceutical
Sinopharm Group
Shandong Luye Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Chengdu Baiyu Pharmaceutical
Yangzijiang Pharmaceutical
Wuxi Kaifu Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pantoprazole Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Tablets
1.2.4 Capsule
1.3 Market by Application
1.3.1 Global Pantoprazole Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Reflux Esophagitis
1.3.3 Gastrinoma
1.3.4 Antimicrobial Agents
1.3.5 Gastrointestinal Hemorrhage
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pantoprazole Market Perspective (2016-2027)
2.2 Pantoprazole Growth Trends by Regions
2.2.1 Pantoprazole Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pantoprazole Historic Market Share by Regions (2016-2021)
2.2.3 Pantoprazole Forecasted Market Size by Regions (2022-2027)
2.3 Pantoprazole Industry Dynamic
2.3.1 Pantoprazole Market Trends
2.3.2 Pantoprazole Market Drivers
2.3.3 Pantoprazole Market Challenges
2.3.4 Pantoprazole Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pantoprazole Players by Revenue
3.1.1 Global Top Pantoprazole Players by Revenue (2016-2021)
3.1.2 Global Pantoprazole Revenue Market Share by Players (2016-2021)
3.2 Global Pantoprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pantoprazole Revenue
3.4 Global Pantoprazole Market Concentration Ratio
3.4.1 Global Pantoprazole Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pantoprazole Revenue in 2020
3.5 Pantoprazole Key Players Head office and Area Served
3.6 Key Players Pantoprazole Product Solution and Service
3.7 Date of Enter into Pantoprazole Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pantoprazole Breakdown Data by Type
4.1 Global Pantoprazole Historic Market Size by Type (2016-2021)
4.2 Global Pantoprazole Forecasted Market Size by Type (2022-2027)
5 Pantoprazole Breakdown Data by Application
5.1 Global Pantoprazole Historic Market Size by Application (2016-2021)
5.2 Global Pantoprazole Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pantoprazole Market Size (2016-2027)
6.2 North America Pantoprazole Market Size by Type
6.2.1 North America Pantoprazole Market Size by Type (2016-2021)
6.2.2 North America Pantoprazole Market Size by Type (2022-2027)
6.2.3 North America Pantoprazole Market Size by Type (2016-2027)
6.3 North America Pantoprazole Market Size by Application
6.3.1 North America Pantoprazole Market Size by Application (2016-2021)
6.3.2 North America Pantoprazole Market Size by Application (2022-2027)
6.3.3 North America Pantoprazole Market Size by Application (2016-2027)
6.4 North America Pantoprazole Market Size by Country
6.4.1 North America Pantoprazole Market Size by Country (2016-2021)
6.4.2 North America Pantoprazole Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pantoprazole Market Size (2016-2027)
7.2 Europe Pantoprazole Market Size by Type
7.2.1 Europe Pantoprazole Market Size by Type (2016-2021)
7.2.2 Europe Pantoprazole Market Size by Type (2022-2027)
7.2.3 Europe Pantoprazole Market Size by Type (2016-2027)
7.3 Europe Pantoprazole Market Size by Application
7.3.1 Europe Pantoprazole Market Size by Application (2016-2021)
7.3.2 Europe Pantoprazole Market Size by Application (2022-2027)
7.3.3 Europe Pantoprazole Market Size by Application (2016-2027)
7.4 Europe Pantoprazole Market Size by Country
7.4.1 Europe Pantoprazole Market Size by Country (2016-2021)
7.4.2 Europe Pantoprazole Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pantoprazole Market Size (2016-2027)
8.2 Asia-Pacific Pantoprazole Market Size by Type
8.2.1 Asia-Pacific Pantoprazole Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pantoprazole Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pantoprazole Market Size by Type (2016-2027)
8.3 Asia-Pacific Pantoprazole Market Size by Application
8.3.1 Asia-Pacific Pantoprazole Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pantoprazole Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pantoprazole Market Size by Application (2016-2027)
8.4 Asia-Pacific Pantoprazole Market Size by Region
8.4.1 Asia-Pacific Pantoprazole Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pantoprazole Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pantoprazole Market Size (2016-2027)
9.2 Latin America Pantoprazole Market Size by Type
9.2.1 Latin America Pantoprazole Market Size by Type (2016-2021)
9.2.2 Latin America Pantoprazole Market Size by Type (2022-2027)
9.2.3 Latin America Pantoprazole Market Size by Type (2016-2027)
9.3 Latin America Pantoprazole Market Size by Application
9.3.1 Latin America Pantoprazole Market Size by Application (2016-2021)
9.3.2 Latin America Pantoprazole Market Size by Application (2022-2027)
9.3.3 Latin America Pantoprazole Market Size by Application (2016-2027)
9.4 Latin America Pantoprazole Market Size by Country
9.4.1 Latin America Pantoprazole Market Size by Country (2016-2021)
9.4.2 Latin America Pantoprazole Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pantoprazole Market Size (2016-2027)
10.2 Middle East & Africa Pantoprazole Market Size by Type
10.2.1 Middle East & Africa Pantoprazole Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pantoprazole Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pantoprazole Market Size by Type (2016-2027)
10.3 Middle East & Africa Pantoprazole Market Size by Application
10.3.1 Middle East & Africa Pantoprazole Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pantoprazole Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pantoprazole Market Size by Application (2016-2027)
10.4 Middle East & Africa Pantoprazole Market Size by Country
10.4.1 Middle East & Africa Pantoprazole Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pantoprazole Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Pantoprazole Introduction
11.1.4 Takeda Revenue in Pantoprazole Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 Actavis (TEVA )
11.2.1 Actavis (TEVA ) Company Details
11.2.2 Actavis (TEVA ) Business Overview
11.2.3 Actavis (TEVA ) Pantoprazole Introduction
11.2.4 Actavis (TEVA ) Revenue in Pantoprazole Business (2016-2021)
11.2.5 Actavis (TEVA ) Recent Development
11.3 Mantra Pharma
11.3.1 Mantra Pharma Company Details
11.3.2 Mantra Pharma Business Overview
11.3.3 Mantra Pharma Pantoprazole Introduction
11.3.4 Mantra Pharma Revenue in Pantoprazole Business (2016-2021)
11.3.5 Mantra Pharma Recent Development
11.4 Nora Pharma
11.4.1 Nora Pharma Company Details
11.4.2 Nora Pharma Business Overview
11.4.3 Nora Pharma Pantoprazole Introduction
11.4.4 Nora Pharma Revenue in Pantoprazole Business (2016-2021)
11.4.5 Nora Pharma Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Pantoprazole Introduction
11.5.4 Abbott Revenue in Pantoprazole Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Angita Pharma
11.6.1 Angita Pharma Company Details
11.6.2 Angita Pharma Business Overview
11.6.3 Angita Pharma Pantoprazole Introduction
11.6.4 Angita Pharma Revenue in Pantoprazole Business (2016-2021)
11.6.5 Angita Pharma Recent Development
11.7 Apotex Corporation
11.7.1 Apotex Corporation Company Details
11.7.2 Apotex Corporation Business Overview
11.7.3 Apotex Corporation Pantoprazole Introduction
11.7.4 Apotex Corporation Revenue in Pantoprazole Business (2016-2021)
11.7.5 Apotex Corporation Recent Development
11.8 Auro Pharma
11.8.1 Auro Pharma Company Details
11.8.2 Auro Pharma Business Overview
11.8.3 Auro Pharma Pantoprazole Introduction
11.8.4 Auro Pharma Revenue in Pantoprazole Business (2016-2021)
11.8.5 Auro Pharma Recent Development
11.9 Devonian
11.9.1 Devonian Company Details
11.9.2 Devonian Business Overview
11.9.3 Devonian Pantoprazole Introduction
11.9.4 Devonian Revenue in Pantoprazole Business (2016-2021)
11.9.5 Devonian Recent Development
11.10 Ahn-Gook Pharmal
11.10.1 Ahn-Gook Pharmal Company Details
11.10.2 Ahn-Gook Pharmal Business Overview
11.10.3 Ahn-Gook Pharmal Pantoprazole Introduction
11.10.4 Ahn-Gook Pharmal Revenue in Pantoprazole Business (2016-2021)
11.10.5 Ahn-Gook Pharmal Recent Development
11.11 GSK
11.11.1 GSK Company Details
11.11.2 GSK Business Overview
11.11.3 GSK Pantoprazole Introduction
11.11.4 GSK Revenue in Pantoprazole Business (2016-2021)
11.11.5 GSK Recent Development
11.12 Eurofarma Laboratorios
11.12.1 Eurofarma Laboratorios Company Details
11.12.2 Eurofarma Laboratorios Business Overview
11.12.3 Eurofarma Laboratorios Pantoprazole Introduction
11.12.4 Eurofarma Laboratorios Revenue in Pantoprazole Business (2016-2021)
11.12.5 Eurofarma Laboratorios Recent Development
11.13 Torrent Pharma
11.13.1 Torrent Pharma Company Details
11.13.2 Torrent Pharma Business Overview
11.13.3 Torrent Pharma Pantoprazole Introduction
11.13.4 Torrent Pharma Revenue in Pantoprazole Business (2016-2021)
11.13.5 Torrent Pharma Recent Development
11.14 Zydus Pharmaceuticals/Cadila Pharma
11.14.1 Zydus Pharmaceuticals/Cadila Pharma Company Details
11.14.2 Zydus Pharmaceuticals/Cadila Pharma Business Overview
11.14.3 Zydus Pharmaceuticals/Cadila Pharma Pantoprazole Introduction
11.14.4 Zydus Pharmaceuticals/Cadila Pharma Revenue in Pantoprazole Business (2016-2021)
11.14.5 Zydus Pharmaceuticals/Cadila Pharma Recent Development
11.15 Northeast Pharmaceutical
11.15.1 Northeast Pharmaceutical Company Details
11.15.2 Northeast Pharmaceutical Business Overview
11.15.3 Northeast Pharmaceutical Pantoprazole Introduction
11.15.4 Northeast Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.15.5 Northeast Pharmaceutical Recent Development
11.16 NCPC
11.16.1 NCPC Company Details
11.16.2 NCPC Business Overview
11.16.3 NCPC Pantoprazole Introduction
11.16.4 NCPC Revenue in Pantoprazole Business (2016-2021)
11.16.5 NCPC Recent Development
11.17 Huarun Shuanghe Pharmaceutical
11.17.1 Huarun Shuanghe Pharmaceutical Company Details
11.17.2 Huarun Shuanghe Pharmaceutical Business Overview
11.17.3 Huarun Shuanghe Pharmaceutical Pantoprazole Introduction
11.17.4 Huarun Shuanghe Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.17.5 Huarun Shuanghe Pharmaceutical Recent Development
11.18 Nanjing Yiheng Pharmaceutical
11.18.1 Nanjing Yiheng Pharmaceutical Company Details
11.18.2 Nanjing Yiheng Pharmaceutical Business Overview
11.18.3 Nanjing Yiheng Pharmaceutical Pantoprazole Introduction
11.18.4 Nanjing Yiheng Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.18.5 Nanjing Yiheng Pharmaceutical Recent Development
11.18 Nanjing Changao Pharmaceutical
11.25.1 Nanjing Changao Pharmaceutical Company Details
11.25.2 Nanjing Changao Pharmaceutical Business Overview
11.25.3 Nanjing Changao Pharmaceutical Pantoprazole Introduction
11.25.4 Nanjing Changao Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.25.5 Nanjing Changao Pharmaceutical Recent Development
11.20 Harbin Yuheng Pharmaceutical
11.20.1 Harbin Yuheng Pharmaceutical Company Details
11.20.2 Harbin Yuheng Pharmaceutical Business Overview
11.20.3 Harbin Yuheng Pharmaceutical Pantoprazole Introduction
11.20.4 Harbin Yuheng Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.20.5 Harbin Yuheng Pharmaceutical Recent Development
11.21 Sinopharm Group
11.21.1 Sinopharm Group Company Details
11.21.2 Sinopharm Group Business Overview
11.21.3 Sinopharm Group Pantoprazole Introduction
11.21.4 Sinopharm Group Revenue in Pantoprazole Business (2016-2021)
11.21.5 Sinopharm Group Recent Development
11.22 Shandong Luye Pharmaceutical
11.22.1 Shandong Luye Pharmaceutical Company Details
11.22.2 Shandong Luye Pharmaceutical Business Overview
11.22.3 Shandong Luye Pharmaceutical Pantoprazole Introduction
11.22.4 Shandong Luye Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.22.5 Shandong Luye Pharmaceutical Recent Development
11.23 Shandong Luoxin Pharmaceutical Group
11.23.1 Shandong Luoxin Pharmaceutical Group Company Details
11.23.2 Shandong Luoxin Pharmaceutical Group Business Overview
11.23.3 Shandong Luoxin Pharmaceutical Group Pantoprazole Introduction
11.23.4 Shandong Luoxin Pharmaceutical Group Revenue in Pantoprazole Business (2016-2021)
11.23.5 Shandong Luoxin Pharmaceutical Group Recent Development
11.24 Chengdu Baiyu Pharmaceutical
11.24.1 Chengdu Baiyu Pharmaceutical Company Details
11.24.2 Chengdu Baiyu Pharmaceutical Business Overview
11.24.3 Chengdu Baiyu Pharmaceutical Pantoprazole Introduction
11.24.4 Chengdu Baiyu Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.24.5 Chengdu Baiyu Pharmaceutical Recent Development
11.25 Yangzijiang Pharmaceutical
11.25.1 Yangzijiang Pharmaceutical Company Details
11.25.2 Yangzijiang Pharmaceutical Business Overview
11.25.3 Yangzijiang Pharmaceutical Pantoprazole Introduction
11.25.4 Yangzijiang Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.25.5 Yangzijiang Pharmaceutical Recent Development
11.26 Wuxi Kaifu Pharmaceutical
11.26.1 Wuxi Kaifu Pharmaceutical Company Details
11.26.2 Wuxi Kaifu Pharmaceutical Business Overview
11.26.3 Wuxi Kaifu Pharmaceutical Pantoprazole Introduction
11.26.4 Wuxi Kaifu Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.26.5 Wuxi Kaifu Pharmaceutical Recent Development
11.27 Hangzhou Zhongmei Huadong Pharmaceutical
11.27.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Details
11.27.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
11.27.3 Hangzhou Zhongmei Huadong Pharmaceutical Pantoprazole Introduction
11.27.4 Hangzhou Zhongmei Huadong Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.27.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Development
11.28 Liaoning Kangshi Pharmaceutical
11.28.1 Liaoning Kangshi Pharmaceutical Company Details
11.28.2 Liaoning Kangshi Pharmaceutical Business Overview
11.28.3 Liaoning Kangshi Pharmaceutical Pantoprazole Introduction
11.28.4 Liaoning Kangshi Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.28.5 Liaoning Kangshi Pharmaceutical Recent Development
11.29 Shanghai AIDEFA Pharmaceutical
11.29.1 Shanghai AIDEFA Pharmaceutical Company Details
11.29.2 Shanghai AIDEFA Pharmaceutical Business Overview
11.29.3 Shanghai AIDEFA Pharmaceutical Pantoprazole Introduction
11.29.4 Shanghai AIDEFA Pharmaceutical Revenue in Pantoprazole Business (2016-2021)
11.29.5 Shanghai AIDEFA Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pantoprazole Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Tablets
Table 4. Key Players of Capsule
Table 5. Global Pantoprazole Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pantoprazole Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pantoprazole Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pantoprazole Market Share by Regions (2016-2021)
Table 9. Global Pantoprazole Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pantoprazole Market Share by Regions (2022-2027)
Table 11. Pantoprazole Market Trends
Table 12. Pantoprazole Market Drivers
Table 13. Pantoprazole Market Challenges
Table 14. Pantoprazole Market Restraints
Table 15. Global Pantoprazole Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pantoprazole Market Share by Players (2016-2021)
Table 17. Global Top Pantoprazole Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pantoprazole as of 2020)
Table 18. Ranking of Global Top Pantoprazole Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pantoprazole Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pantoprazole Product Solution and Service
Table 22. Date of Enter into Pantoprazole Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pantoprazole Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pantoprazole Revenue Market Share by Type (2016-2021)
Table 26. Global Pantoprazole Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pantoprazole Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pantoprazole Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pantoprazole Revenue Market Share by Application (2016-2021)
Table 30. Global Pantoprazole Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pantoprazole Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pantoprazole Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pantoprazole Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pantoprazole Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pantoprazole Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pantoprazole Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pantoprazole Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pantoprazole Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pantoprazole Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pantoprazole Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pantoprazole Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pantoprazole Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pantoprazole Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pantoprazole Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pantoprazole Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pantoprazole Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pantoprazole Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pantoprazole Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pantoprazole Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pantoprazole Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pantoprazole Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pantoprazole Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pantoprazole Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pantoprazole Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pantoprazole Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pantoprazole Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pantoprazole Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pantoprazole Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pantoprazole Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pantoprazole Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pantoprazole Market Size by Country (2022-2027) & (US$ Million)
Table 62. Takeda Company Details
Table 63. Takeda Business Overview
Table 64. Takeda Pantoprazole Product
Table 65. Takeda Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Actavis (TEVA ) Company Details
Table 68. Actavis (TEVA ) Business Overview
Table 69. Actavis (TEVA ) Pantoprazole Product
Table 70. Actavis (TEVA ) Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 71. Actavis (TEVA ) Recent Development
Table 72. Mantra Pharma Company Details
Table 73. Mantra Pharma Business Overview
Table 74. Mantra Pharma Pantoprazole Product
Table 75. Mantra Pharma Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 76. Mantra Pharma Recent Development
Table 77. Nora Pharma Company Details
Table 78. Nora Pharma Business Overview
Table 79. Nora Pharma Pantoprazole Product
Table 80. Nora Pharma Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 81. Nora Pharma Recent Development
Table 82. Abbott Company Details
Table 83. Abbott Business Overview
Table 84. Abbott Pantoprazole Product
Table 85. Abbott Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 86. Abbott Recent Development
Table 87. Angita Pharma Company Details
Table 88. Angita Pharma Business Overview
Table 89. Angita Pharma Pantoprazole Product
Table 90. Angita Pharma Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 91. Angita Pharma Recent Development
Table 92. Apotex Corporation Company Details
Table 93. Apotex Corporation Business Overview
Table 94. Apotex Corporation Pantoprazole Product
Table 95. Apotex Corporation Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 96. Apotex Corporation Recent Development
Table 97. Auro Pharma Company Details
Table 98. Auro Pharma Business Overview
Table 99. Auro Pharma Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 100. Auro Pharma Recent Development
Table 101. Devonian Company Details
Table 102. Devonian Business Overview
Table 103. Devonian Pantoprazole Product
Table 104. Devonian Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 105. Devonian Recent Development
Table 106. Ahn-Gook Pharmal Company Details
Table 107. Ahn-Gook Pharmal Business Overview
Table 108. Ahn-Gook Pharmal Pantoprazole Product
Table 109. Ahn-Gook Pharmal Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 110. Ahn-Gook Pharmal Recent Development
Table 111. GSK Company Details
Table 112. GSK Business Overview
Table 113. GSK Pantoprazole Product
Table 114. GSK Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 115. GSK Recent Development
Table 116. Eurofarma Laboratorios Company Details
Table 117. Eurofarma Laboratorios Business Overview
Table 118. Eurofarma Laboratorios Pantoprazole Product
Table 119. Eurofarma Laboratorios Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 120. Eurofarma Laboratorios Recent Development
Table 121. Torrent Pharma Company Details
Table 122. Torrent Pharma Business Overview
Table 123. Torrent Pharma Pantoprazole Product
Table 124. Torrent Pharma Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 125. Torrent Pharma Recent Development
Table 126. Zydus Pharmaceuticals/Cadila Pharma Company Details
Table 127. Zydus Pharmaceuticals/Cadila Pharma Business Overview
Table 128. Zydus Pharmaceuticals/Cadila Pharma Pantoprazole Product
Table 129. Zydus Pharmaceuticals/Cadila Pharma Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 130. Zydus Pharmaceuticals/Cadila Pharma Recent Development
Table 131. Northeast Pharmaceutical Company Details
Table 132. Northeast Pharmaceutical Business Overview
Table 133. Northeast Pharmaceutical Pantoprazole Product
Table 134. Northeast Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 135. Northeast Pharmaceutical Recent Development
Table 136. NCPC Company Details
Table 137. NCPC Business Overview
Table 138. NCPC Pantoprazole Product
Table 139. NCPC Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 140. NCPC Recent Development
Table 141. Huarun Shuanghe Pharmaceutical Company Details
Table 142. Huarun Shuanghe Pharmaceutical Business Overview
Table 143. Huarun Shuanghe Pharmaceutical Pantoprazole Product
Table 144. Huarun Shuanghe Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 145. Huarun Shuanghe Pharmaceutical Recent Development
Table 146. Nanjing Yiheng Pharmaceutical Company Details
Table 147. Nanjing Yiheng Pharmaceutical Business Overview
Table 148. Nanjing Yiheng Pharmaceutical Pantoprazole Product
Table 149. Nanjing Yiheng Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 150. Nanjing Yiheng Pharmaceutical Recent Development
Table 151. Nanjing Changao Pharmaceutical Company Details
Table 152. Nanjing Changao Pharmaceutical Business Overview
Table 153. Nanjing Changao Pharmaceutical Pantoprazole Product
Table 154. Nanjing Changao Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 155. Nanjing Changao Pharmaceutical Recent Development
Table 156. Harbin Yuheng Pharmaceutical Company Details
Table 157. Harbin Yuheng Pharmaceutical Business Overview
Table 158. Harbin Yuheng Pharmaceutical Pantoprazole Product
Table 159. Harbin Yuheng Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 160. Harbin Yuheng Pharmaceutical Recent Development
Table 161. Sinopharm Group Company Details
Table 162. Sinopharm Group Business Overview
Table 163. Sinopharm Group Pantoprazole Product
Table 164. Sinopharm Group Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 165. Sinopharm Group Recent Development
Table 166. Shandong Luye Pharmaceutical Company Details
Table 167. Shandong Luye Pharmaceutical Business Overview
Table 168. Shandong Luye Pharmaceutical Pantoprazole Product
Table 169. Shandong Luye Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 170. Shandong Luye Pharmaceutical Recent Development
Table 171. Shandong Luoxin Pharmaceutical Group Company Details
Table 172. Shandong Luoxin Pharmaceutical Group Business Overview
Table 173. Shandong Luoxin Pharmaceutical Group Pantoprazole Product
Table 174. Shandong Luoxin Pharmaceutical Group Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 175. Shandong Luoxin Pharmaceutical Group Recent Development
Table 176. Chengdu Baiyu Pharmaceutical Company Details
Table 177. Chengdu Baiyu Pharmaceutical Business Overview
Table 178. Chengdu Baiyu Pharmaceutical PantoprazoleProduct
Table 179. Chengdu Baiyu Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 180. Chengdu Baiyu Pharmaceutical Recent Development
Table 181. Yangzijiang Pharmaceutical Company Details
Table 182. Yangzijiang Pharmaceutical Business Overview
Table 183. Yangzijiang Pharmaceutical Pantoprazole Product
Table 184. Yangzijiang Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 185. Yangzijiang Pharmaceutical Recent Development
Table 186. Wuxi Kaifu Pharmaceutical Company Details
Table 187. Wuxi Kaifu Pharmaceutical Business Overview
Table 188. Wuxi Kaifu Pharmaceutical Pantoprazole Product
Table 189. Wuxi Kaifu Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 190. Wuxi Kaifu Pharmaceutical Recent Development
Table 191. Hangzhou Zhongmei Huadong Pharmaceutical Company Details
Table 192. Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
Table 193. Hangzhou Zhongmei Huadong Pharmaceutical Pantoprazole Product
Table 194. Hangzhou Zhongmei Huadong Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 195. Hangzhou Zhongmei Huadong Pharmaceutical Recent Development
Table 196. Liaoning Kangshi Pharmaceutical Company Details
Table 197. Liaoning Kangshi Pharmaceutical Business Overview
Table 198. Liaoning Kangshi Pharmaceutical Pantoprazole Product
Table 199. Liaoning Kangshi Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 200. Liaoning Kangshi Pharmaceutical Recent Development
Table 201. Shanghai AIDEFA Pharmaceutical Company Details
Table 202. Shanghai AIDEFA Pharmaceutical Business Overview
Table 203. Shanghai AIDEFA Pharmaceutical Pantoprazole Product
Table 204. Shanghai AIDEFA Pharmaceutical Revenue in Pantoprazole Business (2016-2021) & (US$ Million)
Table 205. Shanghai AIDEFA Pharmaceutical Recent Development
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pantoprazole Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Tablets Features
Figure 4. Capsule Features
Figure 5. Global Pantoprazole Market Share by Application: 2020 VS 2027
Figure 6. Reflux Esophagitis Case Studies
Figure 7. Gastrinoma Case Studies
Figure 8. Antimicrobial Agents Case Studies
Figure 9. Gastrointestinal Hemorrhage Case Studies
Figure 10. Other Case Studies
Figure 11. Pantoprazole Report Years Considered
Figure 12. Global Pantoprazole Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Pantoprazole Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Pantoprazole Market Share by Regions: 2020 VS 2027
Figure 15. Global Pantoprazole Market Share by Regions (2022-2027)
Figure 16. Global Pantoprazole Market Share by Players in 2020
Figure 17. Global Top Pantoprazole Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pantoprazole as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Pantoprazole Revenue in 2020
Figure 19. Global Pantoprazole Revenue Market Share by Type (2016-2021)
Figure 20. Global Pantoprazole Revenue Market Share by Type (2022-2027)
Figure 21. North America Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Pantoprazole Market Share by Type (2016-2027)
Figure 23. North America Pantoprazole Market Share by Application (2016-2027)
Figure 24. North America Pantoprazole Market Share by Country (2016-2027)
Figure 25. United States Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pantoprazole Market Share by Type (2016-2027)
Figure 29. Europe Pantoprazole Market Share by Application (2016-2027)
Figure 30. Europe Pantoprazole Market Share by Country (2016-2027)
Figure 31. Germany Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pantoprazole Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Pantoprazole Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Pantoprazole Market Share by Region (2016-2027)
Figure 41. China Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pantoprazole Market Share by Type (2016-2027)
Figure 49. Latin America Pantoprazole Market Share by Application (2016-2027)
Figure 50. Latin America Pantoprazole Market Share by Country (2016-2027)
Figure 51. Mexico Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pantoprazole Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Pantoprazole Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Pantoprazole Market Share by Country (2016-2027)
Figure 57. Turkey Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Pantoprazole Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Takeda Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 61. Actavis (TEVA ) Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 62. Mantra Pharma Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 63. Nora Pharma Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 65. Angita Pharma Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 66. Apotex Corporation Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 67. Auro Pharma Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 68. Devonian Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 69. Ahn-Gook Pharmal Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 70. GSK Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 71. Eurofarma Laboratorios Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 72. Torrent Pharma Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 73. Zydus Pharmaceuticals/Cadila Pharma Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 74. Northeast Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 75. NCPC Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 76. Huarun Shuanghe Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 77. Nanjing Yiheng Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 78. Nanjing Changao Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 79. Harbin Yuheng Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 80. Sinopharm Group Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 81. Shandong Luye Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 82. Shandong Luoxin Pharmaceutical Group Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 83. Chengdu Baiyu Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 84. Yangzijiang Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 85. Wuxi Kaifu Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 86. Hangzhou Zhongmei Huadong Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 87. Liaoning Kangshi Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 88. Shanghai AIDEFA Pharmaceutical Revenue Growth Rate in Pantoprazole Business (2016-2021)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
世界のパントプラゾールナトリウム市場 2021：企業別、地域別、種類・用途別 The Pantoprazole Sodium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界の胃食道逆流症（GERD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market The global Gastroesophageal Reflux Disease (GERD) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-stand…
- 世界の胃食道逆流症（GERD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gastroesophageal Reflux Disease Therapeutics Market The global Gastroesophageal Reflux Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の逆流性腎症治療市場規模・現状・予測（2021年-2027年） Reflux nephropathy is kidney damage (nephropathy) due to urine flowing backward (reflux) from the bladder toward the kidneys. The symptoms of reflux nephropathy are comparable to nephrotic syndrome and infection of the urinary tract, though some individuals may not exhibit any evidence (symptom) of …
- 世界の動脈瘤性クモ膜下出血市場規模・現状・予測（2021年-2027年） Aneurysmal subarachnoid hemorrhage is a condition wherein a brain aneurysm ruptures, resulting in bleeding into the subarachnoid space. Market Analysis and Insights: Global Aneurysmal Subarachnoid Hemorrhage Market The global Aneurysmal Subarachnoid Hemorrhage market size is projected to reach US$ 1…